Current practice for prostate cancer (PCa) diagnosis involves a Digital Rectal Exam ( DRE) and a Prostate-Specific Antigen ( PSA) test followed by a biopsy if that was deemed necessary. However, the negative predictive value (NPV) for transrectal ultrasound-guided prostate biopsies has been shown to be only 74%.

Join for free to read